Shanghai Haoyuan Chemexpress Co., Ltd. (SHA:688131)

China flag China · Delayed Price · Currency is CNY
61.22
-1.49 (-2.38%)
Mar 9, 2026, 3:00 PM CST
42.60%
Market Cap 12.98B
Revenue (ttm) 2.87B
Net Income (ttm) 247.77M
Shares Out 212.10M
EPS (ttm) 1.17
PE Ratio 52.32
Forward PE 31.39
Dividend 0.23 (0.37%)
Ex-Dividend Date Oct 22, 2025
Volume 2,969,029
Average Volume 3,501,031
Open 62.00
Previous Close 62.71
Day's Range 59.76 - 62.00
52-Week Range 31.80 - 90.58
Beta 0.72
RSI 26.50
Earnings Date Apr 23, 2026

About SHA:688131

Shanghai Haoyuan Chemexpress Co., Ltd. researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs. The company offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China. [Read more]

Sector Healthcare
Founded 2006
Employees 3,826
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688131
Full Company Profile

Financial Performance

In 2025, SHA:688131's revenue was 2.87 billion, an increase of 26.35% compared to the previous year's 2.27 billion. Earnings were 247.77 million, an increase of 22.91%.

Financial Statements

News

There is no news available yet.